MYCN and neuroblastoma: Our study shows that induced expression of HIF2α in MYCN-amplified neuroblastoma substantially reduces MYCN protein levels and attenuates proliferation while it induces several features of noradrenergic differentiation and impedes xenograft tumor growth.